SCHEMBL4053837

SCHEMBL4053837

Cn1c(=O)c2[nH]c(-c3ccc(S(=O)(=O)NCCc4ccncc4)cc3)cc2n(C)c1=O

nearest known ligand 0.73

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 16/20 0.73
ADORA3 P0DMS8 10/20 0.73
ADORA1 P30542 10/20 0.73
ADORA2A P29274 3/20 0.56
ALDH1A1 P00352 3/20 0.50
MAPK1 P28482 2/20 0.50
HTT P42858 2/20 0.50
PKM P14618 1/20 0.50
LMNA P02545 2/20 0.49
TSHR P16473 1/20 0.49
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4053850 0.90 ADORA2B (0.65) ADORA2BADORA3ADORA1ADORA2AHTT
SCHEMBL4060758 0.90 ADORA2B (0.65) ADORA2BADORA3ADORA1ADORA2AALDH1A1
SCHEMBL4059617 0.90 ADORA2B (0.75) ADORA2BADORA3ADORA1ADORA2AALDH1A1
SCHEMBL4051486 0.89 ADORA2B (0.71) ADORA2BADORA3ADORA1ADORA2AALDH1A1
SCHEMBL4057341 0.87 ADORA2B (0.57) ADORA2BADORA3ADORA1ADORA2AALDH1A1
SCHEMBL4063349 0.85 ADORA2B (0.68) ADORA2BADORA3ADORA1ADORA2AALDH1A1
SCHEMBL4052706 0.85 ADORA2B (0.73) ADORA2BADORA3ADORA1ADORA2AALDH1A1
SCHEMBL4056690 0.84 ADORA2B (1.00) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL4050484 0.81 ADORA2B (0.63) ADORA2BADORA3ADORA1ADORA2A
SCHEMBL4053029 0.80 ADORA2B (0.58) ADORA2BADORA3ADORA1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7504398-B2 potent and selective antagonists of adenosine receptors; Parkinson's disease, asthma, allergies, inflammation, atherosclerosis, hypertension, gastrointestinal disorders, cell proliferation and autoimmune diseases; sulfonamidation LABORATORIOS ALMIRALL S.A. (ES) 2009-03-17 US disclosed
EP-1492793-B1 NEW-4-(PYRROLOPYRIMIDIN-6-YL)BENZENESULPHONAMIDE DERIVATIVES ALMIRALL LAB (ES) 2008-01-16 EP disclosed